FXAIX
Price
$264.80
Change
+$0.34 (+0.13%)
Updated
Jun 2 closing price
Net Assets
832.15B
VNSCX
Price
$21.07
Change
+$0.05 (+0.24%)
Updated
Jun 2 closing price
Net Assets
579.24M
Interact to see
Advertisement

FXAIX vs VNSCX

Header iconFXAIX vs VNSCX Comparison
Open Charts FXAIX vs VNSCXBanner chart's image
FXAIX vs VNSCX Comparison Chart in %
View a ticker or compare two or three
VS
FXAIX vs. VNSCX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FXAIX is a Buy and VNSCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FXAIX has more cash in the bank: 832B vs. VNSCX (579M). FXAIX pays higher dividends than VNSCX: FXAIX (1.03) vs VNSCX (0.00). FXAIX was incepted earlier than VNSCX: FXAIX (15 years) vs VNSCX (14 years). VNSCX (1.84) is less costly to investors than FXAIX (0.01). VNSCX is a more actively managed with annual turnover of: 64.00 vs. FXAIX (3.00). FXAIX has a lower initial minimum investment than VNSCX: FXAIX (0) vs VNSCX (2500). FXAIX annual gain was more profitable for investors over the last year : 29.57 vs. VNSCX (10.81). FXAIX return over 5 years is better than : 94.64 vs. VNSCX (0.43).
FXAIXVNSCXFXAIX / VNSCX
Total Expense Ratio0.011.841%
Annual Report Gross Expense Ratio0.011.841%
Fund Existence15 years14 years-
Gain YTD11.5628.295139%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets832B579M143,696%
Annual Yield % from dividends1.030.00-
Returns for 1 year29.5710.81274%
Returns for 3 years84.7328.33299%
Returns for 5 years94.640.4322,009%
Returns for 10 years301.4647.82630%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ASYS21.901.25
+6.03%
Amtech Systems
TTI10.890.53
+5.12%
TETRA Technologies
RIO111.672.71
+2.49%
Rio Tinto plc
ROAD111.43-3.31
-2.88%
Construction Partners
ALGS5.17-0.18
-3.36%
Aligos Therapeutics Inc